Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial

INTRODUCTION: Congenital heart disease (CHD) is a major cause of infant mortality. Many infants with CHD require corrective surgery with most operations requiring cardiopulmonary bypass (CPB). CPB triggers a systemic inflammatory response which is associated with low cardiac output syndrome (LCOS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlapbach, Luregn J, Horton, Stephen Brian, Long, Debbie Amanda, Beca, John, Erickson, Simon, Festa, Marino, d’Udekem, Yves, Alphonso, Nelson, Winlaw, David, Johnson, Kerry, Delzoppo, Carmel, van Loon, Kim, Gannon, B, Fooken, Jonas, Blumenthal, Antje, Young, Paul, Jones, Mark, Butt, Warwick, Schibler, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701583/
https://www.ncbi.nlm.nih.gov/pubmed/31420383
http://dx.doi.org/10.1136/bmjopen-2018-026664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701583/
https://www.ncbi.nlm.nih.gov/pubmed/31420383
http://dx.doi.org/10.1136/bmjopen-2018-026664

Ejemplares similares